Machina Capital S.A.S. Amgen Inc Transaction History

Machina Capital S.A.S.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $295,757 - $357,016	1,100 New	1,100 $312,000
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $332,118 - $392,723	1,550 Added 55.36%	4,350 $965,000
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $632,212 - $770,560	2,800 New	2,800 $676,000
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $2.09 Million - $2.68 Million	-11,021 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $1.92 Million - $2.3 Million	11,021 New	11,021 $2.13 Million
Q2 2019 Jul 19, 2019	SELL	$166.7 - $195.41 $634,460 - $743,730	-3,806 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $688,391 - $775,967	3,806 New	3,806 $723,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Machina Capital S.A.S., based on Form 13F filings with the SEC.

Stay updated on Machina Capital S.A.S. with notifications on news.